Sale Completes Awakn's Exit From Healthcare Services To Focus Solely on Biotechnology Research and DevelopmentToronto, Ontario--(Newsfile Corp. - August 1,…
This announcement contains inside informationStrategic Divestment of C4XD's Orexin-1 Receptor Antagonist Programme to Indivior for £15.95 MillionSale encompasses all rights…
OKYO plans a 40-patient OK-101 open-label clinical trial with Dr Pedram Hamrah, Tufts Medical Center, as Principal Investigator, a leading…
CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical…
Company to receive $2 million in upfront payments, with the potential to receive up to $50 million in milestone payments…
WOLF CREEK, MT / ACCESSWIRE / July 26, 2023 / Solo-Dex, a leading player in the development, manufacture, and sales…
TORONTO, ON / ACCESSWIRE / July 26, 2023 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage…
BURLINGTON, Mass. and JERUSALEM, July 26, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…
Continuing to provide a full spectrum of eating disorder treatment, four Selah House Outpatient clinics have rebranded as Aster Springs…
New Findings Support Development of Racemic Tianeptine and (S)-Tianeptine (Estianeptine) as First-in-Class Oral Therapies in Alzheimer’s Disease and Other Psychiatric…